|
Index of reports
> Cases resulting in life threatening events (2)
Below is the selection of adverse event reports related to MS Contin (Morphine) that includes cases resulting in life threatening events.
Adverse event in 74 year old female receiving MS Contin (Morphine)
Reported by a health professional (non-physician/pharmacist) from France on 2007-06-04
Patient: 74 year old female
Adverse reactions / side effects: Respiratory Acidosis, Bronchospasm, Respiratory Depression
Adverse event resulted in: life threatening event
Suspect drug(s):
Valium
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Rivotril
Dosage: dosage regimen reported as 40 mg/ml q.
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
MS Contin
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Sevredol
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Other drugs received by patient: Deroxat; Lioresal; Dafalgan; Irbesartan; Ginkor Fort; Zantac; Spagulax; Combivent; Importal; Magne B6; Serevent
Adverse event in 47 year old female receiving MS Contin (Morphine)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-02-21
Patient: 47 year old female, weighing 52.2 kg (114.8 pounds)
Adverse reactions / side effects: Phlebitis, Muscle Atrophy, Pain, Post Procedural Complication, Condition Aggravated, Appendicitis Perforated, Gangrene, Collapse of Lung, Haematotoxicity, Peritonitis, Complex Regional Pain Syndrome, Joint Sprain, Pleural Effusion
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
MS Contin
Dosage: 1 tablet twice daily-bid- po
Administration route: Oral
Indication: Complex Regional Pain Syndrome
Start date: 2000-08-20
End date: 2007-02-20
Lotrel
Dosage: 1 tab daily po
Administration route: Oral
Indication: Hypertension
Start date: 2001-01-01
End date: 2007-02-20
|
